首页 > 最新文献

Osong Public Health and Research Perspectives最新文献

英文 中文
Number of comorbidities and the risk of delay in seeking treatment for coronary heart disease: a longitudinal study in Bogor City, Indonesia. 合并症数量与冠心病就诊延迟风险:印度尼西亚茂物市的一项纵向研究。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-01 Epub Date: 2024-06-27 DOI: 10.24171/j.phrp.2023.0337
Sulistyowati Tuminah, Lely Indrawati, Woro Riyadina, Tri Wurisastuti, Alfons M Letelay, Nikson Sitorus, Alifa S Putri, Siti Isfandari, Irmansyah Irmansyah

Background: The aim of this study was to investigate the relationship between the number of patient comorbidities and the delays in seeking treatment for coronary heart disease (CHD).

Methods: This longitudinal study utilized secondary data from the Non-Communicable Disease Risk Factor (NCDRF) cohort study conducted in Bogor City. Individuals who participated in the NCDRF cohort study and were diagnosed with CHD within the 6-year study period met the inclusion criteria. Respondents who were not continuously monitored up to the 6th year were excluded. The final sample included data from respondents with CHD who participated in the NCDRF cohort study and were monitored for the full 6-year duration. The final logistic regression analysis was conducted on data collected from 812 participants.

Results: Among the participants with CHD, 702 out of 812 exhibited a delay in seeking treatment. The risk of a delay in seeking treatment was significantly higher among individuals without comorbidities, with an odds ratio (OR) of 3.5 (95% confidence interval [CI], 1.735-7.036; p<0.001). Among those with a single comorbidity, the risk of delay in seeking treatment was still notable (OR, 2.6; 95% CI, 1.259-5.418; p=0.010) when compared to those with 2 or more comorbidities. These odds were adjusted for age, sex, education level, and health insurance status.

Conclusion: The proportion of patients with CHD who delayed seeking treatment was high, particularly among individuals with no comorbidities. Low levels of comorbidity also appeared to correlate with a greater tendency to delay in seeking treatment.

研究背景本研究旨在调查患者合并症数量与冠心病(CHD)就诊延迟之间的关系:这项纵向研究利用了在茂物市进行的非传染性疾病风险因素(NCDRF)队列研究的二手数据。参与 NCDRF 队列研究并在 6 年研究期内被诊断出患有冠心病的人符合纳入标准。未持续监测至第 6 年的受访者被排除在外。最终样本包括参与 NCDRF 队列研究并在整个 6 年研究期间接受监测的患有冠心病的受访者的数据。最终的逻辑回归分析是针对 812 名参与者的数据进行的:结果:在 812 名患有慢性阻塞性肺病的参与者中,有 702 人表现出延迟就医的情况。没有合并症的患者延迟就医的风险明显更高,赔率比(OR)为 3.5(95% 置信区间 [CI],1.735-7.036;p):延迟就医的心脏病患者比例很高,尤其是在无合并症的患者中。合并症水平低似乎也与更倾向于延迟就医有关。
{"title":"Number of comorbidities and the risk of delay in seeking treatment for coronary heart disease: a longitudinal study in Bogor City, Indonesia.","authors":"Sulistyowati Tuminah, Lely Indrawati, Woro Riyadina, Tri Wurisastuti, Alfons M Letelay, Nikson Sitorus, Alifa S Putri, Siti Isfandari, Irmansyah Irmansyah","doi":"10.24171/j.phrp.2023.0337","DOIUrl":"10.24171/j.phrp.2023.0337","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to investigate the relationship between the number of patient comorbidities and the delays in seeking treatment for coronary heart disease (CHD).</p><p><strong>Methods: </strong>This longitudinal study utilized secondary data from the Non-Communicable Disease Risk Factor (NCDRF) cohort study conducted in Bogor City. Individuals who participated in the NCDRF cohort study and were diagnosed with CHD within the 6-year study period met the inclusion criteria. Respondents who were not continuously monitored up to the 6th year were excluded. The final sample included data from respondents with CHD who participated in the NCDRF cohort study and were monitored for the full 6-year duration. The final logistic regression analysis was conducted on data collected from 812 participants.</p><p><strong>Results: </strong>Among the participants with CHD, 702 out of 812 exhibited a delay in seeking treatment. The risk of a delay in seeking treatment was significantly higher among individuals without comorbidities, with an odds ratio (OR) of 3.5 (95% confidence interval [CI], 1.735-7.036; p<0.001). Among those with a single comorbidity, the risk of delay in seeking treatment was still notable (OR, 2.6; 95% CI, 1.259-5.418; p=0.010) when compared to those with 2 or more comorbidities. These odds were adjusted for age, sex, education level, and health insurance status.</p><p><strong>Conclusion: </strong>The proportion of patients with CHD who delayed seeking treatment was high, particularly among individuals with no comorbidities. Low levels of comorbidity also appeared to correlate with a greater tendency to delay in seeking treatment.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11237317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strengthening the health system, including innovative budget mobilization, is an urgent issue for the Expanded Programme on Immunization. 加强卫生系统,包括以创新方式调动预算,是扩大免疫计划面临的一个紧迫问题。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-01 Epub Date: 2024-06-27 DOI: 10.24171/j.phrp.2024.0181
Jong-Koo Lee
{"title":"Strengthening the health system, including innovative budget mobilization, is an urgent issue for the Expanded Programme on Immunization.","authors":"Jong-Koo Lee","doi":"10.24171/j.phrp.2024.0181","DOIUrl":"10.24171/j.phrp.2024.0181","url":null,"abstract":"","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11237321/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Mycobacterium bovis outbreak among exhibition animals at a zoo in the Republic of Korea: the first contact investigation of zoonotic tuberculosis. 大韩民国动物园展出动物中爆发的牛分枝杆菌病:人畜共患结核病的首次接触调查。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-01 Epub Date: 2024-05-17 DOI: 10.24171/j.phrp.2023.0228
Hye Young Lee, Yunhyung Kwon, Sang-Eun Lee, Jieun Kim, Hoyong Choi

Background: Between July 2, 2021, and September 20, 2022, a Mycobacterium bovis outbreak occurred among exhibition animals at a zoo in the Republic of Korea. This study was conducted to assess the likelihood of M. bovis transmission to human contacts through a contact investigation and to implement preventive treatment for latent tuberculosis infection (LTBI).

Methods: In this descriptive study, the Korea Disease Control and Prevention Agency conducted a contact investigation, which included interviews, interferon-gamma release assay (IGRA) tests, and chest X-rays. Contacts underwent IGRA testing on 2 occasions: initial testing of 29 contacts (15 in the first cluster of infection and 14 in the second cluster) and follow-up testing of the 15 contacts in the first cluster.

Results: The study included 29 participants, 18 of whom were male (62.1%) and 11 female (37.9%). The mean participant age was 37.3 years (standard deviation, 9.6 years). In the initial IGRA tests, 6 of the 29 participants tested positive, indicating a prevalence of 20.7%. Following prolonged exposure, 1 additional positive case was detected in follow-up testing, raising the prevalence of LTBI to 24.1%. None of the contacts had active tuberculosis. Among the 7 individuals with positive results, 2 (28.6%) underwent treatment for LTBI.

Conclusion: This study faced challenges in confirming the transmission of M. bovis infection from infected animals to humans in the Republic of Korea. Nevertheless, adopting a One Health approach necessitates the implementation of surveillance systems and infection control protocols, particularly for occupational groups at high risk of exposure.

背景:2021年7月2日至2022年9月20日期间,大韩民国一家动物园的展览动物中爆发了牛分枝杆菌疫情。本研究旨在通过接触调查评估牛分枝杆菌传播给人类接触者的可能性,并对潜伏肺结核感染(LTBI)实施预防性治疗:在这项描述性研究中,韩国疾病预防控制机构进行了接触者调查,包括访谈、干扰素-γ释放测定(IGRA)检测和胸部 X 光检查。接触者接受了两次 IGRA 检测:对 29 名接触者(第一组感染者中的 15 人和第二组感染者中的 14 人)进行了初次检测,并对第一组感染者中的 15 名接触者进行了后续检测:研究包括 29 名参与者,其中 18 名男性(62.1%),11 名女性(37.9%)。参与者的平均年龄为 37.3 岁(标准差为 9.6 岁)。在最初的 IGRA 检测中,29 名参与者中有 6 人检测呈阳性,患病率为 20.7%。随着接触时间的延长,在后续检测中又发现了 1 例阳性病例,使 LTBI 患病率上升至 24.1%。接触者中没有人患有活动性肺结核。在结果呈阳性的 7 人中,有 2 人(28.6%)接受了治疗:本研究在确认大韩民国受感染动物向人类传播牛海绵状芽孢杆菌感染方面面临挑战。尽管如此,要采取 "一体健康 "方法,就必须实施监测系统和感染控制方案,尤其是针对高危职业人群。
{"title":"A Mycobacterium bovis outbreak among exhibition animals at a zoo in the Republic of Korea: the first contact investigation of zoonotic tuberculosis.","authors":"Hye Young Lee, Yunhyung Kwon, Sang-Eun Lee, Jieun Kim, Hoyong Choi","doi":"10.24171/j.phrp.2023.0228","DOIUrl":"10.24171/j.phrp.2023.0228","url":null,"abstract":"<p><strong>Background: </strong>Between July 2, 2021, and September 20, 2022, a Mycobacterium bovis outbreak occurred among exhibition animals at a zoo in the Republic of Korea. This study was conducted to assess the likelihood of M. bovis transmission to human contacts through a contact investigation and to implement preventive treatment for latent tuberculosis infection (LTBI).</p><p><strong>Methods: </strong>In this descriptive study, the Korea Disease Control and Prevention Agency conducted a contact investigation, which included interviews, interferon-gamma release assay (IGRA) tests, and chest X-rays. Contacts underwent IGRA testing on 2 occasions: initial testing of 29 contacts (15 in the first cluster of infection and 14 in the second cluster) and follow-up testing of the 15 contacts in the first cluster.</p><p><strong>Results: </strong>The study included 29 participants, 18 of whom were male (62.1%) and 11 female (37.9%). The mean participant age was 37.3 years (standard deviation, 9.6 years). In the initial IGRA tests, 6 of the 29 participants tested positive, indicating a prevalence of 20.7%. Following prolonged exposure, 1 additional positive case was detected in follow-up testing, raising the prevalence of LTBI to 24.1%. None of the contacts had active tuberculosis. Among the 7 individuals with positive results, 2 (28.6%) underwent treatment for LTBI.</p><p><strong>Conclusion: </strong>This study faced challenges in confirming the transmission of M. bovis infection from infected animals to humans in the Republic of Korea. Nevertheless, adopting a One Health approach necessitates the implementation of surveillance systems and infection control protocols, particularly for occupational groups at high risk of exposure.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11237313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Periodontitis and non-communicable diseases in a Brazilian population, a cross-sectional study, Vila Velha-ES, Brazil. 巴西人口牙周炎与非传染性疾病的横断面研究,巴西 Vila Velha-ES。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-01 Epub Date: 2024-06-27 DOI: 10.24171/j.phrp.2024.0021
Gustavo Vital de Mendonça, Crispim Cerutti Junior, Alfredo Carlos Rodrigues Feitosa, Brígida Franco Sampaio de Mendonça, Lucia Helena Sagrillo Pimassoni

Background: The objective of this study was to examine the hypothesis that periodontal disease is associated with chronic non-communicable diseases.

Methods: In this cross-sectional study, we evaluated the periodontal health condition of the population, based on the community periodontal index, as well as the number of missing teeth and the presence of systemic health conditions. We quantified the association between oral health and the presence of chronic diseases using simple logistic regression, adjusting for confounding factors including age, smoking, and overweight.

Results: The study population consisted of 334 volunteers, aged between 19 and 81 years. In patients over 45 years old, periodontal disease was found to be significantly associated with hypertension and diabetes. Furthermore, in female patients, periodontal disease was significantly associated with hypertension, diabetes, and cancer.

Conclusion: Our findings indicate that periodontal disease is positively and significantly associated with both arterial hypertension and diabetes, independent of potential confounding factors.

背景:本研究旨在探讨牙周病与慢性非传染性疾病相关的假设:本研究旨在探讨牙周病与慢性非传染性疾病相关的假设:在这项横断面研究中,我们根据社区牙周指数评估了人口的牙周健康状况,以及缺牙数量和是否存在全身性健康问题。我们使用简单的逻辑回归方法量化了口腔健康与慢性疾病之间的关系,并对年龄、吸烟和超重等混杂因素进行了调整:研究对象包括 334 名志愿者,年龄在 19 岁至 81 岁之间。在 45 岁以上的患者中,牙周病与高血压和糖尿病有显著相关性。此外,在女性患者中,牙周病与高血压、糖尿病和癌症有明显关联:我们的研究结果表明,牙周病与动脉高血压和糖尿病均有显著的正相关关系,不受潜在混杂因素的影响。
{"title":"Periodontitis and non-communicable diseases in a Brazilian population, a cross-sectional study, Vila Velha-ES, Brazil.","authors":"Gustavo Vital de Mendonça, Crispim Cerutti Junior, Alfredo Carlos Rodrigues Feitosa, Brígida Franco Sampaio de Mendonça, Lucia Helena Sagrillo Pimassoni","doi":"10.24171/j.phrp.2024.0021","DOIUrl":"10.24171/j.phrp.2024.0021","url":null,"abstract":"<p><strong>Background: </strong>The objective of this study was to examine the hypothesis that periodontal disease is associated with chronic non-communicable diseases.</p><p><strong>Methods: </strong>In this cross-sectional study, we evaluated the periodontal health condition of the population, based on the community periodontal index, as well as the number of missing teeth and the presence of systemic health conditions. We quantified the association between oral health and the presence of chronic diseases using simple logistic regression, adjusting for confounding factors including age, smoking, and overweight.</p><p><strong>Results: </strong>The study population consisted of 334 volunteers, aged between 19 and 81 years. In patients over 45 years old, periodontal disease was found to be significantly associated with hypertension and diabetes. Furthermore, in female patients, periodontal disease was significantly associated with hypertension, diabetes, and cancer.</p><p><strong>Conclusion: </strong>Our findings indicate that periodontal disease is positively and significantly associated with both arterial hypertension and diabetes, independent of potential confounding factors.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11237320/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and patterns of post-COVID-19 symptoms in recovered patients of Delhi, India: a population-based study. 印度德里 COVID-19 后症状康复者的患病率和模式:一项基于人群的研究。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-01 Epub Date: 2024-05-17 DOI: 10.24171/j.phrp.2023.0251
Nidhi Bhatnagar, Mongjam Meghachandra Singh, Hitakshi Sharma, Suruchi Mishra, Gurmeet Singh, Shivani Rao, Amod Borle, Tanu Anand, Naresh Kumar, Binita Goswami, Sarika Singh, Mahima Kapoor, Sumeet Singla, Bembem Khuraijam, Nita Khurana, Urvi Sharma, Suneela Garg

Background: Post-coronavirus disease 2019 (COVID-19) symptoms were widely reported. However, data on post-COVID-19 conditions following infection with the Omicron variant remained scarce. This prospective study was conducted to understand the prevalence, patterns, and duration of symptoms in patients who had recovered from COVID-19.

Methods: A prospective study was conducted across 11 districts of Delhi, India, among individuals who had recovered from COVID-19. Study participants were enrolled, and then returned for post-recovery follow-up at 3 months and 6 months interval.

Results: The mean age of study participants was 42.07 years, with a standard deviation of 14.89 years. The majority of the participants (79.7%) reported experiencing post-COVID-19 symptoms. The most common symptoms included joint pain (36.0%), persistent dry cough (35.7%), anxiety (28.4%), and shortness of breath (27.1%). Other symptoms were persistent fatigue (21.6%), persistent headache (20.0%), forgetfulness (19.7%), and limb weakness (18.6%). The longest duration of symptom was observed to be anxiety (138.75±54.14 days), followed by fatigue (137.57±48.33 days), shortness of breath (131.89±60.21 days), and joint pain/swelling (131.59±58.76 days). At the first follow-up visit, 2.2% of participants presented with abnormal electrocardiogram readings, but no abnormalities were noticed during the second follow-up. Additionally, 4.06% of participants exhibited abnormal chest X-ray findings at the first followup, which decreased to 2.16% by the second visit.

Conclusion: The most frequently reported post-COVID-19 symptoms were joint pain, dry cough, anxiety and shortness of breath. These clinical symptoms persisted for up to 6 months, with evidence of multi-system involvement. Consequently, findings highlighted the need for long-term follow-up during the post-COVID-19 period.

背景:科罗纳病毒病 2019(COVID-19)后症状被广泛报道。然而,有关感染奥米克隆变种后 COVID-19 后症状的数据仍然很少。本前瞻性研究旨在了解 COVID-19 康复患者症状的发生率、模式和持续时间:在印度德里的 11 个区对 COVID-19 康复者进行了前瞻性研究。研究人员注册后,分别在 3 个月和 6 个月后进行康复后随访:研究参与者的平均年龄为 42.07 岁,标准差为 14.89 岁。大多数参与者(79.7%)表示出现了 COVID-19 后症状。最常见的症状包括关节疼痛(36.0%)、持续干咳(35.7%)、焦虑(28.4%)和呼吸急促(27.1%)。其他症状包括持续疲劳(21.6%)、持续头痛(20.0%)、健忘(19.7%)和四肢无力(18.6%)。症状持续时间最长的是焦虑(138.75±54.14 天),其次是疲劳(137.57±48.33 天)、气短(131.89±60.21 天)和关节疼痛/肿胀(131.59±58.76 天)。在第一次随访时,2.2%的参与者出现心电图读数异常,但在第二次随访时未发现异常。此外,4.06%的参与者在首次随访时发现胸部X光检查结果异常,第二次随访时这一比例降至2.16%:结论:COVID-19 后最常见的症状是关节疼痛、干咳、焦虑和气短。这些临床症状持续时间长达 6 个月,有证据表明涉及多个系统。因此,研究结果凸显了在 COVID-19 后期间进行长期随访的必要性。
{"title":"Prevalence and patterns of post-COVID-19 symptoms in recovered patients of Delhi, India: a population-based study.","authors":"Nidhi Bhatnagar, Mongjam Meghachandra Singh, Hitakshi Sharma, Suruchi Mishra, Gurmeet Singh, Shivani Rao, Amod Borle, Tanu Anand, Naresh Kumar, Binita Goswami, Sarika Singh, Mahima Kapoor, Sumeet Singla, Bembem Khuraijam, Nita Khurana, Urvi Sharma, Suneela Garg","doi":"10.24171/j.phrp.2023.0251","DOIUrl":"10.24171/j.phrp.2023.0251","url":null,"abstract":"<p><strong>Background: </strong>Post-coronavirus disease 2019 (COVID-19) symptoms were widely reported. However, data on post-COVID-19 conditions following infection with the Omicron variant remained scarce. This prospective study was conducted to understand the prevalence, patterns, and duration of symptoms in patients who had recovered from COVID-19.</p><p><strong>Methods: </strong>A prospective study was conducted across 11 districts of Delhi, India, among individuals who had recovered from COVID-19. Study participants were enrolled, and then returned for post-recovery follow-up at 3 months and 6 months interval.</p><p><strong>Results: </strong>The mean age of study participants was 42.07 years, with a standard deviation of 14.89 years. The majority of the participants (79.7%) reported experiencing post-COVID-19 symptoms. The most common symptoms included joint pain (36.0%), persistent dry cough (35.7%), anxiety (28.4%), and shortness of breath (27.1%). Other symptoms were persistent fatigue (21.6%), persistent headache (20.0%), forgetfulness (19.7%), and limb weakness (18.6%). The longest duration of symptom was observed to be anxiety (138.75±54.14 days), followed by fatigue (137.57±48.33 days), shortness of breath (131.89±60.21 days), and joint pain/swelling (131.59±58.76 days). At the first follow-up visit, 2.2% of participants presented with abnormal electrocardiogram readings, but no abnormalities were noticed during the second follow-up. Additionally, 4.06% of participants exhibited abnormal chest X-ray findings at the first followup, which decreased to 2.16% by the second visit.</p><p><strong>Conclusion: </strong>The most frequently reported post-COVID-19 symptoms were joint pain, dry cough, anxiety and shortness of breath. These clinical symptoms persisted for up to 6 months, with evidence of multi-system involvement. Consequently, findings highlighted the need for long-term follow-up during the post-COVID-19 period.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11237315/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gender differences in hepatitis A seropositivity rates according to the Republic of Korea's vaccination policy. 大韩民国疫苗接种政策下甲型肝炎血清阳性率的性别差异。
IF 4.3 Q1 Medicine Pub Date : 2024-04-16 DOI: 10.24171/j.phrp.2023.0263
Hyunjin Son, Sunhyun Ahn, Wonseo Park, Gayoung Chun, U. Go, Sang Gon Lee, E. Lee
ObjectivesThis study aimed to investigate differences in the anti-hepatitis A (HAV) antibody seropositivity rate by age and gender.MethodsWe collected information on anti-HAV immunoglobulin G and immunoglobulin M status from samples submitted for HAV antibody testing in 2012-2022. A total of 1,333,615 cases were included in the analysis.ResultsBy age, the seropositivity rate was represented by a U-shaped curve, such that the rate was low for the group aged 20 to 39 years and higher in those who were younger or older. Over time, the curve shifted rightward, and the seropositivity rate declined gradually in the group aged 35 to 39 years and older. A gender-based difference in antibody seropositivity rate was especially noticeable in the group aged 20 to 29 years. This difference between genders widened in the participants' early 20s-when men in the Republic of Korea enlist in the military-and the divergence continued subsequently for older individuals.ConclusionThese results indicate a higher risk of severe infection among older individuals and a gender-based difference in seroprevalence. Therefore, it is necessary to implement policies to promote vaccination in adults.
本研究旨在调查不同年龄和性别人群抗甲型肝炎(HAV)抗体血清阳性率的差异。方法 我们收集了 2012-2022 年送检 HAV 抗体样本中抗 HAV 免疫球蛋白 G 和免疫球蛋白 M 状态的信息。结果 按年龄划分,血清阳性率呈 U 型曲线,20 至 39 岁人群的血清阳性率较低,而年龄较小或较大的人群的血清阳性率较高。随着时间的推移,曲线右移,35 至 39 岁及以上年龄组的血清阳性率逐渐下降。在 20 至 29 岁的人群中,抗体血清阳性率的性别差异尤为明显。这一性别差异在参与者 20 岁出头(大韩民国男性应征入伍的年龄段)时有所扩大,而在年龄较大的人群中,这一差异仍在继续。因此,有必要实施促进成人接种疫苗的政策。
{"title":"Gender differences in hepatitis A seropositivity rates according to the Republic of Korea's vaccination policy.","authors":"Hyunjin Son, Sunhyun Ahn, Wonseo Park, Gayoung Chun, U. Go, Sang Gon Lee, E. Lee","doi":"10.24171/j.phrp.2023.0263","DOIUrl":"https://doi.org/10.24171/j.phrp.2023.0263","url":null,"abstract":"Objectives\u0000This study aimed to investigate differences in the anti-hepatitis A (HAV) antibody seropositivity rate by age and gender.\u0000\u0000\u0000Methods\u0000We collected information on anti-HAV immunoglobulin G and immunoglobulin M status from samples submitted for HAV antibody testing in 2012-2022. A total of 1,333,615 cases were included in the analysis.\u0000\u0000\u0000Results\u0000By age, the seropositivity rate was represented by a U-shaped curve, such that the rate was low for the group aged 20 to 39 years and higher in those who were younger or older. Over time, the curve shifted rightward, and the seropositivity rate declined gradually in the group aged 35 to 39 years and older. A gender-based difference in antibody seropositivity rate was especially noticeable in the group aged 20 to 29 years. This difference between genders widened in the participants' early 20s-when men in the Republic of Korea enlist in the military-and the divergence continued subsequently for older individuals.\u0000\u0000\u0000Conclusion\u0000These results indicate a higher risk of severe infection among older individuals and a gender-based difference in seroprevalence. Therefore, it is necessary to implement policies to promote vaccination in adults.","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140697093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors associated with the timely diagnosis of malaria and the utilization of types of healthcare facilities: a retrospective study in the Republic of Korea. 与及时诊断疟疾和利用各类医疗设施相关的因素:大韩民国的一项回顾性研究。
IF 4.3 Q1 Medicine Pub Date : 2024-04-16 DOI: 10.24171/j.phrp.2023.0349
HyunJung Kim, Sangwoo Tak, So-Dam Lee, Seongwoo Park, Kyungwon Hwang
ObjectivesThis study aimed to analyze trends in the timely diagnosis of malaria cases over the past 10 years in relation to the utilization of different types of healthcare facilities.MethodsThe study included 3,697 confirmed and suspected cases of malaria reported between January 1, 2013, and December 31, 2022, in the national integrative disease and healthcare management system. Some cases lacking a case report or with information missing from the case report were excluded from the analysis. A generalized linear model with a Poisson distribution was constructed to estimate rate ratios and 95% confidence intervals adjusted for other variables, such as distance.ResultsWhen cases involving diagnosis >5 days after symptom onset in confirmed patients (5DD) were examined according to the type of healthcare facility, the rate ratio of 5DD cases was found to be higher for public health facilities than for tertiary hospitals. Specifically, the rate ratio was higher when the diagnosis was established at a tertiary hospital, even after a participant had visited primary or secondary hospitals. In an analysis adjusted for the distance to each participant's healthcare facility, the results did not differ substantially from the results of the crude analysis.ConclusionIt is imperative to improve the diagnostic capabilities of public facilities and raise awareness of malaria at primary healthcare facilities for effective prevention and control.
本研究旨在分析过去 10 年间疟疾病例及时诊断的趋势与不同类型医疗机构的使用情况之间的关系。研究纳入了 2013 年 1 月 1 日至 2022 年 12 月 31 日期间在国家疾病和医疗保健综合管理系统中报告的 3,697 例疟疾确诊和疑似病例。分析中排除了一些没有病例报告或病例报告中信息缺失的病例。结果根据医疗机构的类型对确诊患者症状出现后 5 天以上的病例(5DD)进行研究,发现公立医疗机构的 5DD 病例比率高于三级医院。具体而言,即使受试者曾在一级或二级医院就诊,如果在三级医院确诊,比率比也会更高。结论 为了有效预防和控制疟疾,必须提高公共医疗机构的诊断能力,并提高基层医疗机构对疟疾的认识。
{"title":"Factors associated with the timely diagnosis of malaria and the utilization of types of healthcare facilities: a retrospective study in the Republic of Korea.","authors":"HyunJung Kim, Sangwoo Tak, So-Dam Lee, Seongwoo Park, Kyungwon Hwang","doi":"10.24171/j.phrp.2023.0349","DOIUrl":"https://doi.org/10.24171/j.phrp.2023.0349","url":null,"abstract":"Objectives\u0000This study aimed to analyze trends in the timely diagnosis of malaria cases over the past 10 years in relation to the utilization of different types of healthcare facilities.\u0000\u0000\u0000Methods\u0000The study included 3,697 confirmed and suspected cases of malaria reported between January 1, 2013, and December 31, 2022, in the national integrative disease and healthcare management system. Some cases lacking a case report or with information missing from the case report were excluded from the analysis. A generalized linear model with a Poisson distribution was constructed to estimate rate ratios and 95% confidence intervals adjusted for other variables, such as distance.\u0000\u0000\u0000Results\u0000When cases involving diagnosis >5 days after symptom onset in confirmed patients (5DD) were examined according to the type of healthcare facility, the rate ratio of 5DD cases was found to be higher for public health facilities than for tertiary hospitals. Specifically, the rate ratio was higher when the diagnosis was established at a tertiary hospital, even after a participant had visited primary or secondary hospitals. In an analysis adjusted for the distance to each participant's healthcare facility, the results did not differ substantially from the results of the crude analysis.\u0000\u0000\u0000Conclusion\u0000It is imperative to improve the diagnostic capabilities of public facilities and raise awareness of malaria at primary healthcare facilities for effective prevention and control.","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140695190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea. COVID-19 疫苗安全研究中心:加强大韩民国 COVID-19 疫苗接种安全性证据的基石。
IF 4.3 Q1 Medicine Pub Date : 2024-04-04 DOI: 10.24171/j.phrp.2023.0343
Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung-Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Jaehun Jung, J. Lee, Ju-Young Shin, Sun-Young Jung, Byung-Joo Park, Nam-Kyong Choi
The COVID-19 Vaccine Safety Research Committee (CoVaSC) was established in November 2021 to address the growing need for independent, in-depth scientific evidence on adverse events (AEs) following coronavirus disease 2019 (COVID-19) vaccination. This initiative was requested by the Korea Disease Control and Prevention Agency and led by the National Academy of Medicine of Korea. In September 2022, the COVID-19 Vaccine Safety Research Center was established, strengthening CoVaSC's initiatives. The center has conducted various studies on the safety of COVID-19 vaccines. During CoVaSC's second research year, from September 29, 2022 to July 19, 2023, the center was restructured into 4 departments: Epidemiological Research, Clinical Research, Communication & Education, and International Cooperation & Policy Research. Its main activities include (1) managing CoVaSC and the COVID-19 Vaccine Safety Research Center, (2) surveying domestic and international trends in AE causality investigation, (3) assessing AEs following COVID-19 vaccination, (4) fostering international collaboration and policy research, and (5) organizing regular fora and training sessions for the public and clinicians. Causality assessments have been conducted for 27 diseases, and independent research has been conducted after organizing ad hoc committees comprising both epidemiologists and clinical experts on each AE of interest. The research process included protocol development, data analysis, interpretation of results, and causality assessment. These research outcomes have been shared transparently with the public and healthcare experts through various fora. The COVID-19 Vaccine Safety Research Center plans to continue strengthening and expanding its research activities to provide reliable, high-quality safety information to the public.
COVID-19 疫苗安全研究委员会(CoVaSC)成立于 2021 年 11 月,旨在满足对接种冠状病毒病 2019(COVID-19)疫苗后不良事件(AEs)的独立、深入科学证据日益增长的需求。这一举措是应韩国疾病控制和预防署的要求,由韩国国家医学研究院牵头开展的。2022 年 9 月,COVID-19 疫苗安全研究中心成立,加强了 CoVaSC 的行动。该中心对 COVID-19 疫苗的安全性进行了多项研究。在 CoVaSC 的第二个研究年度,即 2022 年 9 月 29 日至 2023 年 7 月 19 日期间,该中心重组为 4 个部门:流行病学研究部、临床研究部、交流与教育部以及国际合作与政策研究部。其主要活动包括:(1)管理CoVaSC和COVID-19疫苗安全研究中心;(2)调查国内外AE因果关系调查的趋势;(3)评估COVID-19疫苗接种后的AE;(4)促进国际合作和政策研究;(5)为公众和临床医生组织定期论坛和培训。已对 27 种疾病进行了因果关系评估,并在组织了由流行病学家和临床专家组成的特设委员会后,对每种相关的 AE 进行了独立研究。研究过程包括方案制定、数据分析、结果解释和因果关系评估。这些研究成果已通过各种论坛与公众和医疗保健专家透明地分享。COVID-19 疫苗安全性研究中心计划继续加强和扩大其研究活动,为公众提供可靠、高质量的安全性信息。
{"title":"The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea.","authors":"Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung-Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Jaehun Jung, J. Lee, Ju-Young Shin, Sun-Young Jung, Byung-Joo Park, Nam-Kyong Choi","doi":"10.24171/j.phrp.2023.0343","DOIUrl":"https://doi.org/10.24171/j.phrp.2023.0343","url":null,"abstract":"The COVID-19 Vaccine Safety Research Committee (CoVaSC) was established in November 2021 to address the growing need for independent, in-depth scientific evidence on adverse events (AEs) following coronavirus disease 2019 (COVID-19) vaccination. This initiative was requested by the Korea Disease Control and Prevention Agency and led by the National Academy of Medicine of Korea. In September 2022, the COVID-19 Vaccine Safety Research Center was established, strengthening CoVaSC's initiatives. The center has conducted various studies on the safety of COVID-19 vaccines. During CoVaSC's second research year, from September 29, 2022 to July 19, 2023, the center was restructured into 4 departments: Epidemiological Research, Clinical Research, Communication & Education, and International Cooperation & Policy Research. Its main activities include (1) managing CoVaSC and the COVID-19 Vaccine Safety Research Center, (2) surveying domestic and international trends in AE causality investigation, (3) assessing AEs following COVID-19 vaccination, (4) fostering international collaboration and policy research, and (5) organizing regular fora and training sessions for the public and clinicians. Causality assessments have been conducted for 27 diseases, and independent research has been conducted after organizing ad hoc committees comprising both epidemiologists and clinical experts on each AE of interest. The research process included protocol development, data analysis, interpretation of results, and causality assessment. These research outcomes have been shared transparently with the public and healthcare experts through various fora. The COVID-19 Vaccine Safety Research Center plans to continue strengthening and expanding its research activities to provide reliable, high-quality safety information to the public.","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140745811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishment of a registry of clinical data and bioresources for rare nervous system diseases. 建立罕见神经系统疾病临床数据和生物资源登记册。
IF 4.3 Q1 Medicine Pub Date : 2024-04-01 Epub Date: 2024-04-30 DOI: 10.24171/j.phrp.2023.0353
Dayoung Kim, Sooyoung Kim, Jin Myoung Seok, Kyong Jin Shin, Eungseok Oh, Mi Young Jeon, Joungkyu Park, Hee Jin Chang, Jinyoung Youn, Jeeyoung Oh, Eunhee Sohn, Jinse Park, Jin Whan Cho, Byoung Joon Kim

Rare diseases are predominantly genetic or inherited, and patients with these conditions frequently exhibit neurological symptoms. Diagnosing and treating many rare diseases is a complex challenge, and their low prevalence complicates the performance of research, which in turn hinders the advancement of therapeutic options. One strategy to address this issue is the creation of national or international registries for rare diseases, which can help researchers monitor and investigate their natural progression. In the Republic of Korea, we established a registry across 5 centers that focuses on 3 rare diseases, all of which are characterized by gait disturbances resulting from motor system dysfunction. The registry will collect clinical information and human bioresources from patients with amyotrophic lateral sclerosis, spinocerebellar ataxia, and hereditary spastic paraplegia. These resources will be stored at ICreaT and the National Biobank of Korea. Once the registry is complete, the data will be made publicly available for further research. Through this registry, our research team is dedicated to identifying genetic variants that are specific to Korean patients, uncovering biomarkers that show a strong correlation with clinical symptoms, and leveraging this information for early diagnosis and the development of treatments.

罕见病主要是遗传性疾病,这些疾病的患者经常表现出神经系统症状。诊断和治疗许多罕见病是一项复杂的挑战,而罕见病的低患病率又使研究工作复杂化,这反过来又阻碍了治疗方案的发展。解决这一问题的策略之一是建立国家或国际罕见病登记册,这有助于研究人员监测和调查罕见病的自然进展。在大韩民国,我们在 5 个中心建立了一个登记处,重点关注 3 种罕见疾病,所有这些疾病都以运动系统功能障碍导致的步态障碍为特征。登记处将收集肌萎缩侧索硬化症、脊髓小脑共济失调症和遗传性痉挛性截瘫患者的临床信息和人体生物资源。这些资源将储存在 ICreaT 和韩国国家生物库中。登记完成后,这些数据将公开供进一步研究使用。通过该登记处,我们的研究团队致力于确定韩国患者特有的基因变异,发现与临床症状密切相关的生物标志物,并利用这些信息进行早期诊断和开发治疗方法。
{"title":"Establishment of a registry of clinical data and bioresources for rare nervous system diseases.","authors":"Dayoung Kim, Sooyoung Kim, Jin Myoung Seok, Kyong Jin Shin, Eungseok Oh, Mi Young Jeon, Joungkyu Park, Hee Jin Chang, Jinyoung Youn, Jeeyoung Oh, Eunhee Sohn, Jinse Park, Jin Whan Cho, Byoung Joon Kim","doi":"10.24171/j.phrp.2023.0353","DOIUrl":"10.24171/j.phrp.2023.0353","url":null,"abstract":"<p><p>Rare diseases are predominantly genetic or inherited, and patients with these conditions frequently exhibit neurological symptoms. Diagnosing and treating many rare diseases is a complex challenge, and their low prevalence complicates the performance of research, which in turn hinders the advancement of therapeutic options. One strategy to address this issue is the creation of national or international registries for rare diseases, which can help researchers monitor and investigate their natural progression. In the Republic of Korea, we established a registry across 5 centers that focuses on 3 rare diseases, all of which are characterized by gait disturbances resulting from motor system dysfunction. The registry will collect clinical information and human bioresources from patients with amyotrophic lateral sclerosis, spinocerebellar ataxia, and hereditary spastic paraplegia. These resources will be stored at ICreaT and the National Biobank of Korea. Once the registry is complete, the data will be made publicly available for further research. Through this registry, our research team is dedicated to identifying genetic variants that are specific to Korean patients, uncovering biomarkers that show a strong correlation with clinical symptoms, and leveraging this information for early diagnosis and the development of treatments.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082444/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140899870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychiatric adverse events associated with the COVID-19 vaccines approved in the Republic of Korea: a systematic review. 与大韩民国批准的 COVID-19 疫苗相关的精神不良事件:系统综述。
IF 4.3 Q1 Medicine Pub Date : 2024-04-01 Epub Date: 2024-03-28 DOI: 10.24171/j.phrp.2023.0325
Seungeun Ryoo, Miyoung Choi, Nam-Kyong Choi, Hyoung-Shik Shin, Jun Hee Woo, Byung-Joo Park, Sanghoon Oh

This systematic review evaluated psychiatric adverse events (AEs) following vaccination against coronavirus disease 2019 (COVID-19). We included studies that reported or investigated psychiatric AEs in individuals who had received an approved COVID-19 vaccine in the Republic of Korea. Systematic electronic searches of Ovid-Medline, Embase, CENTRAL, and KoreaMed databases were conducted on March 22, 2023. Risk of bias was assessed using the Risk of Bias Assessment Tool for Non-randomized Studies 2.0. The study protocol was registered in the International Prospective Register of Systematic Reviews (CRD42023449422). Of the 301 articles initially selected, 7 were included in the final analysis. All studies reported on sleep disturbances, and 2 highlighted anxiety-related AEs. Sleep disorders like insomnia and narcolepsy were the most prevalent AEs, while depression was not reported. Our review suggests that these AEs may have been influenced by biological mechanisms as well as the broader psychosocial context of the COVID-19 pandemic. Although this study had limitations, such as a primary focus on the BNT162b2 vaccine and an observational study design, it offered a systematic, multi-vaccine analysis that fills a critical gap in the existing literature. This review underscores the need for continued surveillance of psychiatric AEs and guides future research to investigate underlying mechanisms, identify risk factors, and inform clinical management.

本系统综述评估了接种2019年冠状病毒病(COVID-19)疫苗后的精神不良事件(AEs)。我们纳入了报告或调查在大韩民国接种了经批准的 COVID-19 疫苗的人发生精神科不良事件的研究。我们于2023年3月22日对Ovid-Medline、Embase、CENTRAL和KoreaMed数据库进行了系统的电子检索。使用非随机研究偏倚风险评估工具 2.0 对偏倚风险进行了评估。研究方案已在《国际系统综述前瞻性注册》(CRD42023449422)中注册。在初步筛选出的 301 篇文章中,有 7 篇被纳入最终分析。所有研究都报告了睡眠障碍,其中 2 项研究强调了与焦虑相关的 AE。失眠和嗜睡症等睡眠障碍是最常见的不良反应,而抑郁症则未见报道。我们的综述表明,这些 AEs 可能受到生物机制以及 COVID-19 大流行的广泛社会心理背景的影响。尽管这项研究存在局限性,如主要关注 BNT162b2 疫苗和观察性研究设计,但它提供了系统的多疫苗分析,填补了现有文献的一个重要空白。本综述强调了持续监测精神科 AEs 的必要性,并为未来的研究提供了指导,以调查潜在机制、确定风险因素并为临床管理提供信息。
{"title":"Psychiatric adverse events associated with the COVID-19 vaccines approved in the Republic of Korea: a systematic review.","authors":"Seungeun Ryoo, Miyoung Choi, Nam-Kyong Choi, Hyoung-Shik Shin, Jun Hee Woo, Byung-Joo Park, Sanghoon Oh","doi":"10.24171/j.phrp.2023.0325","DOIUrl":"10.24171/j.phrp.2023.0325","url":null,"abstract":"<p><p>This systematic review evaluated psychiatric adverse events (AEs) following vaccination against coronavirus disease 2019 (COVID-19). We included studies that reported or investigated psychiatric AEs in individuals who had received an approved COVID-19 vaccine in the Republic of Korea. Systematic electronic searches of Ovid-Medline, Embase, CENTRAL, and KoreaMed databases were conducted on March 22, 2023. Risk of bias was assessed using the Risk of Bias Assessment Tool for Non-randomized Studies 2.0. The study protocol was registered in the International Prospective Register of Systematic Reviews (CRD42023449422). Of the 301 articles initially selected, 7 were included in the final analysis. All studies reported on sleep disturbances, and 2 highlighted anxiety-related AEs. Sleep disorders like insomnia and narcolepsy were the most prevalent AEs, while depression was not reported. Our review suggests that these AEs may have been influenced by biological mechanisms as well as the broader psychosocial context of the COVID-19 pandemic. Although this study had limitations, such as a primary focus on the BNT162b2 vaccine and an observational study design, it offered a systematic, multi-vaccine analysis that fills a critical gap in the existing literature. This review underscores the need for continued surveillance of psychiatric AEs and guides future research to investigate underlying mechanisms, identify risk factors, and inform clinical management.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082440/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140865957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Osong Public Health and Research Perspectives
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1